Fresenius Medical Care AG & Co. (NYSE:FMS) Holdings Cut by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. reduced its position in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) by 2.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,816 shares of the company’s stock after selling 1,840 shares during the period. Crossmark Global Holdings Inc.’s holdings in Fresenius Medical Care AG & Co. were worth $3,406,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Neuberger Berman Group LLC increased its stake in Fresenius Medical Care AG & Co. by 4.0% during the third quarter. Neuberger Berman Group LLC now owns 55,188 shares of the company’s stock valued at $2,698,000 after purchasing an additional 2,107 shares during the last quarter. Intrust Bank NA increased its stake in Fresenius Medical Care AG & Co. by 21.1% during the third quarter. Intrust Bank NA now owns 16,865 shares of the company’s stock valued at $825,000 after purchasing an additional 2,934 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Fresenius Medical Care AG & Co. during the third quarter worth about $527,000. Parametric Portfolio Associates LLC grew its position in shares of Fresenius Medical Care AG & Co. by 8.9% during the third quarter. Parametric Portfolio Associates LLC now owns 431,183 shares of the company’s stock worth $21,081,000 after acquiring an additional 35,064 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of Fresenius Medical Care AG & Co. by 4.8% during the third quarter. Bank of New York Mellon Corp now owns 53,263 shares of the company’s stock worth $2,604,000 after acquiring an additional 2,429 shares during the last quarter. Institutional investors and hedge funds own 2.57% of the company’s stock.

Several equities analysts have recently commented on FMS shares. Morgan Stanley lowered shares of Fresenius Medical Care AG & Co. from an “overweight” rating to an “equal weight” rating in a research report on Monday, December 11th. Zacks Investment Research lowered shares of Fresenius Medical Care AG & Co. from a “buy” rating to a “hold” rating in a research report on Tuesday, January 16th. DZ Bank reaffirmed a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Monday, December 18th. Nord/LB reaffirmed a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Tuesday, January 2nd. Finally, UBS Group raised shares of Fresenius Medical Care AG & Co. from a “sell” rating to a “neutral” rating in a report on Thursday, January 4th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $56.00.

Shares of Fresenius Medical Care AG & Co. (NYSE:FMS) traded up $0.41 on Friday, hitting $54.61. The stock had a trading volume of 75,630 shares, compared to its average volume of 142,294. The firm has a market cap of $33,219.40, a P/E ratio of 24.49, a price-to-earnings-growth ratio of 2.06 and a beta of 0.52. Fresenius Medical Care AG & Co. has a one year low of $40.21 and a one year high of $57.94. The company has a quick ratio of 0.98, a current ratio of 1.22 and a debt-to-equity ratio of 0.55.

COPYRIGHT VIOLATION WARNING: “Fresenius Medical Care AG & Co. (NYSE:FMS) Holdings Cut by Crossmark Global Holdings Inc.” was first posted by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://weekherald.com/2018/02/17/crossmark-global-holdings-inc-lowers-stake-in-fresenius-medical-care-ag-co-fms.html.

Fresenius Medical Care AG & Co. Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply